Brief: BlackRock Inc's Long Position In H-Share Of Sinopharm Group Rises To 7.08% - HKEX Filing
Aug 31 (Reuters) - Hong Kong stock exchange filing:
* BLACKROCK INC'S LONG POSITION IN H-SHARE OF SINOPHARM
GROUP
1099.HK INCREASED TO 7.08% ON AUG 26 FROM 6.89% - HKEX FILING
Source text https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20220831E00014&sa2=ns&sid=36601&sd=31/08/2021&ed=31/08/2022&sa1=cl&scsd=31/08/2021&sced=31/08/2022&sc=01099&src=Main&lang=EN&tk=ds
Further company coverage: 1099.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For